--- title: "Oncology Institute (TOI.US) — 财务报表" type: "Symbol" locale: "zh-CN" url: "https://longbridge.com/zh-CN/quote/TOI.US/norm.md" symbol: "TOI.US" name: "Oncology Institute" parent: "https://longbridge.com/zh-CN/quote/TOI.US.md" datetime: "2026-03-09T22:49:26.454Z" locales: - [en](https://longbridge.com/en/quote/TOI.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/TOI.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/TOI.US/norm.md) --- > 支持的语言: [English](https://longbridge.com/en/quote/TOI.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/TOI.US/norm.md) # Oncology Institute (TOI.US) — 财务报表 ## 利润表 (USD) | 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | | --- | --- | --- | --- | --- | --- | | 每股收益 | -0.1413 | -0.1501 | -0.2100 | -0.1467 | -0.1800 | | ROE | 518.18% | 2858.22% | -1485.33% | -454.13% | -236.72% | | 营业收入 | 136.56M | 119.80M | 104.41M | 100.27M | 99.90M | | 净利润 | -13.77M | -13.99M | -16.07M | -10.83M | -13.22M | | 营业利润 | -8.05M | -11.21M | -9.91M | -11.93M | -13.85M | | 毛利率 | 13.85% | 14.61% | 16.52% | 14.60% | 14.38% | | 净利率 | -12.09% | -14.20% | -18.76% | -13.15% | -16.13% | | 利润含金量 | - | - | - | -284.97% | -1691.45% | ## 资产负债表 (USD) | 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | | --- | --- | --- | --- | --- | --- | | 资产与负债 | 163.62M | 159.80M | 164.00M | 172.72M | 179.18M | | 权益乘数 | -13.33 | -17.79 | 32.35 | 48.12 | 11.57 | | 每股净资产 | -0.1258 | -0.0963 | 0.0570 | 0.0474 | 0.2049 | | 资产周转率 | 2.69 | 2.50 | 2.19 | 2.06 | 1.91 | | 现金及短投 | 27.66M | 30.29M | 39.74M | 49.67M | 47.40M | | 存货与应收 | 18.88M | 15.79M | 12.31M | 10.04M | 10.11M | | 长期投资 | 33.98M | 34.74M | 35.33M | 37.67M | 39.36M | | 净债务 | 75.97M | 73.26M | 62.66M | 73.58M | 75.66M | ## 现金流量表 (USD) | 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | | --- | --- | --- | --- | --- | --- | | 经营现金流 | -12.63M | -10.20M | -4.99M | 4.19M | 819000.00 | | 投资现金流 | -604000.00 | -1.21M | -202000.00 | -1.75M | 10.40M | | 融资现金流 | 10.60M | 1.96M | -4.74M | -164000.00 | -243000.00 | | 自由现金流 | -9.95M | -8.29M | -303375.00 | 5.47M | 7.96M | | 现金流充裕率 | -1491.15% | -704.56% | -24.26% | 143.31% | -209.46% | | 举债与偿债 | - | - | - | - | - | | 资本支出 | -604000.00 | -1.21M | -328000.00 | -1.75M | 402000.00 |